高龄医院获得性肺炎患者预防性应用氟康唑抗真菌治疗的疗效分析(5)
[15]陈新谦.新编药物学[M].14版.北京：人民卫生出版社，2002：109-110.
[16]陈莉文，席玉胜，孟猛，等.氟康唑对院内深部真菌感染的预防观察与分析[J].中国现代医学杂志，2006，16(12)：1861-1863.
[17] Grant S M，Clissold S P.Fluconazole.A review of its pharmacodynamic and pharmacokinetic properties，and therapeutic potential in superficial and systemic mycoses[J].Drugs，1990，40(6)：862.
[18] Yapar N.Epidemiology and risk factors for invasive candidiasis[J].Ther Clin Risk Manag，2014，10(1)：95-105.
[19] Montagna M T，Caggiano G，Lovero G，et al.Epidemiology of invasive fungal infection in the intensive care unit：Results of a multicenter Italian survey(AURORA Project)[J].Infection，2013，41(3)：645-653.
[20] Drgona L，Khachatryan A，Stephens J，et al.Clinical and economic burden of invasive fungal diseases in Europe： Focus on pre-emptive and empirical treatment of Aspergillus and Candida species[J].Eur J Clin Microbiol Infect Dis，2014，33(1)：7-21.
[21]谭玉萍，王朝晖.高龄老年肺炎65例临床分析[J].中国实用医药，2007，2(4)：27-28.
(收稿日期：2016-05-18) (本文编辑：程旭然), 百拇医药(胡伟 李尔然)
[16]陈莉文，席玉胜，孟猛，等.氟康唑对院内深部真菌感染的预防观察与分析[J].中国现代医学杂志，2006，16(12)：1861-1863.
[17] Grant S M，Clissold S P.Fluconazole.A review of its pharmacodynamic and pharmacokinetic properties，and therapeutic potential in superficial and systemic mycoses[J].Drugs，1990，40(6)：862.
[18] Yapar N.Epidemiology and risk factors for invasive candidiasis[J].Ther Clin Risk Manag，2014，10(1)：95-105.
[19] Montagna M T，Caggiano G，Lovero G，et al.Epidemiology of invasive fungal infection in the intensive care unit：Results of a multicenter Italian survey(AURORA Project)[J].Infection，2013，41(3)：645-653.
[20] Drgona L，Khachatryan A，Stephens J，et al.Clinical and economic burden of invasive fungal diseases in Europe： Focus on pre-emptive and empirical treatment of Aspergillus and Candida species[J].Eur J Clin Microbiol Infect Dis，2014，33(1)：7-21.
[21]谭玉萍，王朝晖.高龄老年肺炎65例临床分析[J].中国实用医药，2007，2(4)：27-28.
(收稿日期：2016-05-18) (本文编辑：程旭然), 百拇医药(胡伟 李尔然)